SCF ENCYCLOPEDIA ENTRY

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) — POSTPARTUM

SCF-RDOS Registry Code: SCF-RDOS-PPD-PULM-001

Disease Type Classification: Postpartum Pulmonary Disorder → Acute Respiratory Failure Syndrome → Acute Respiratory Distress Syndrome (ARDS)

SCF Classification Status: Catastrophic Pulmonary-Critical Care Syndrome

SCF Severity Classification: Life-Threatening Maternal Respiratory Failure Disorder

Adaptive Module Activation

• Universal Core Module
• Pulmonary Biology Expansion
• Critical Care Expansion
• Maternal Survival Biology Expansion
• Endothelial Biology Expansion
• Immunology Expansion
• Microcirculation Biology Expansion
• Mitochondrial Biology Expansion
• Oxygen Transport Biology Expansion
• Multi-Organ Systems Expansion
• SCF Pathophysiology Protocol (Extended Version)
• SCF Universal Cross-System Analysis Module

1. SCOPE & POSITIONING

Definition

Acute Respiratory Distress Syndrome (ARDS) is a severe inflammatory lung injury syndrome characterized by diffuse alveolar-capillary membrane damage, pulmonary edema, impaired gas exchange, refractory hypoxemia, and respiratory failure.

Within postpartum medicine, ARDS is among the most severe complications encountered in maternal critical care and frequently develops secondary to catastrophic obstetric or systemic disorders.

Within the SCF framework, ARDS is classified as:

A catastrophic pulmonary interface failure syndrome characterized by disruption of alveolar-capillary integrity, inflammatory amplification, endothelial dysfunction, oxygen-transfer collapse, mitochondrial bioenergetic stress, and progressive maternal respiratory system failure.

2. ETIOLOGY AND TRIGGER CLUSTERS

Cluster A — Septic ARDS

Associated Disorders:

• Puerperal sepsis
• Septic shock
• Group A streptococcal infection
• Clostridial uterine infection

Primary Failure:

Inflammatory pulmonary injury

Cluster B — Hemorrhagic ARDS

Associated Disorders:

• Massive obstetric hemorrhage
• Hemorrhagic shock
• Massive transfusion

Primary Failure:

Inflammatory-endothelial pulmonary dysfunction

Cluster C — Hypertensive ARDS

Associated Disorders:

• HELLP syndrome
• Severe preeclampsia
• Eclampsia

Primary Failure:

Endothelial injury and capillary leak

Cluster D — Embolic ARDS

Associated Disorders:

• Amniotic fluid embolism
• Pulmonary thromboembolism

Primary Failure:

Pulmonary inflammatory catastrophe

Cluster E — Aspiration-Associated ARDS

Associated Disorders:

• Gastric aspiration
• Anesthesia-related aspiration injury

Primary Failure:

Direct alveolar injury

Cluster F — Transfusion-Associated ARDS

Associated Disorders:

• Transfusion-related acute lung injury (TRALI)

Primary Failure:

Immune-mediated pulmonary injury

3. SCF CLASSIFICATION

SCF Disease Category

Catastrophic Pulmonary Interface Failure Syndrome

SCF Functional Class

Maternal Oxygen Exchange Collapse Disorder

SCF Fault Tier Classification

4. ETIOPATHOGENIC CORE

Central SCF Principle

ARDS develops when pulmonary inflammatory and endothelial injury overwhelm protective mechanisms maintaining alveolar-capillary integrity.

The syndrome reflects failure of:

• Alveolar barrier function
• Endothelial homeostasis
• Gas exchange systems
• Oxygen transport networks
• Pulmonary fluid regulation
• Cellular bioenergetic adaptation

Core SCF Equation

Pulmonary Injury

Endothelial Dysfunction

Alveolar-Capillary Failure

=

ARDS

5. SCF FAULT ARCHITECTURE

Tier I — Inflammatory Activation

Initiating Events:

• Infection
• Shock
• Embolism
• Aspiration

Result:

Cytokine activation

Tier II — Endothelial and Epithelial Injury

Features:

• Barrier disruption
• Increased permeability
• Cellular injury

Result:

Capillary leakage

Tier III — Pulmonary Edema

Features:

• Protein-rich alveolar fluid accumulation
• Surfactant dysfunction
• Reduced lung compliance

Result:

Gas exchange impairment

Tier IV — ARDS

Features:

• Severe hypoxemia
• Bilateral pulmonary infiltrates
• Respiratory distress

Result:

Respiratory failure

Tier V — Systemic Progression

Features:

• MODS
• Shock
• Multi-organ hypoxia

Result:

Critical illness

Tier VI — Maternal Survival Collapse

Features:

• Refractory hypoxemia
• Irreversible organ injury

Result:

Maternal death risk

6. MOLECULAR MULTI-OMICS PATHOGENESIS MAP

Genomics

Affected Pathways:

• Inflammatory regulation
• Endothelial resilience
• Oxidative stress responses
• Lung repair mechanisms

Transcriptomics

Activation of:

• NF-κB signaling
• Cytokine transcription programs
• Hypoxia response pathways

Proteomics

Elevated Biomarkers:

• IL-1β
• IL-6
• TNF-α
• VEGF
• Angiopoietin-2

Metabolomics

Features:

• Lactate elevation
• Oxidative stress
• ATP depletion
• Hypoxia-associated metabolic shifts

Endotheliomics

Features:

• Glycocalyx degradation
• Capillary leak
• Pulmonary vascular dysfunction

Mitochondriomics

Features:

• Reduced oxidative phosphorylation
• Mitochondrial injury
• Bioenergetic collapse

Interactomics

Failure of:

• Pulmonary-cardiovascular integration
• Oxygen delivery networks

7. SCF PATHOGENESIS FLOW

Maternal Trigger Event

↓

Inflammatory Activation

↓

Pulmonary Endothelial Injury

↓

Alveolar Epithelial Damage

↓

Barrier Failure

↓

Capillary Leak

↓

Pulmonary Edema

↓

Surfactant Dysfunction

↓

Alveolar Collapse

↓

Impaired Gas Exchange

↓

Hypoxemia

↓

ARDS

↓

MODS

↓

Maternal Critical Illness Syndrome

↓

Maternal Survival System Collapse

8. SCF FUNCTIONAL MATRIX

9. SCF TRINITY FRAMEWORK

Structural Integrity Failure

Affected Structures:

• Alveolar epithelium
• Pulmonary capillary endothelium
• Interstitial architecture

Primary Failure:

Loss of alveolar-capillary barrier integrity

Energetic Integrity Failure

Affected Systems:

• Oxygen uptake
• Oxygen transport
• Cellular ATP generation

Primary Failure:

Systemic oxygen deficit

Informational Integrity Failure

Affected Systems:

• Pulmonary regulatory signaling
• Immune communication
• Cardiopulmonary coordination

Primary Failure:

Loss of synchronized respiratory adaptation

10. SCF PATHOPHYSIOLOGY PROTOCOL — EXTENDED VERSION

Etiopathogenic Core

Catastrophic failure of the pulmonary oxygen-exchange interface resulting in progressive hypoxemia, bioenergetic collapse, and systemic organ dysfunction.

SCF Fault Domains

1. Pulmonary injury
2. Endothelial dysfunction
3. Capillary leak
4. Alveolar flooding
5. Hypoxemia
6. Cellular energy failure
7. Organ dysfunction

Trigger → Symptomatology → Fault Mapping

11. SCF THERAPEUTIC MECHANISMS (PCR BRAID)

PREVENTATIVE

Objectives

Prevent progression of pulmonary injury.

Targets:

• Sepsis prevention
• Early shock management
• Aspiration prevention
• Transfusion optimization

CURATIVE

Objectives

Restore oxygenation and pulmonary function.

Targets:

• Hypoxemia
• Inflammation
• Capillary leak
• Respiratory failure

Clinical Interventions:

• Mechanical ventilation
• Lung-protective ventilation
• Prone positioning (when appropriate)
• Fluid optimization
• Cause-directed treatment

RESTORATIVE

Objectives

Restore pulmonary architecture and long-term respiratory function.

Targets:

• Alveolar repair
• Endothelial recovery
• Fibrosis prevention
• Functional rehabilitation

Potential SCF Strategies:

• Alveolar regenerative therapeutics
• Endothelial restoration systems
• Mitochondrial rescue platforms
• Precision anti-inflammatory technologies

12. CURRENT STANDARD OF CARE

Diagnostic Evaluation

Clinical Findings

Common symptoms:

• Severe dyspnea
• Tachypnea
• Hypoxemia
• Respiratory distress

Diagnostic Criteria

Key findings:

• Acute onset
• Bilateral pulmonary infiltrates
• Impaired oxygenation
• Non-cardiogenic pulmonary edema

Imaging

• Chest radiography
• Chest CT
• Lung ultrasound

Laboratory Studies

• Arterial blood gases
• CBC
• Inflammatory markers
• Lactate
• Organ function testing

Treatment

Critical Care Management

• ICU admission
• Mechanical ventilation
• Oxygenation support
• Hemodynamic stabilization

Cause-Specific Management

• Sepsis treatment
• Hemorrhage control
• Embolism management
• Infection source control

13. TRANSLATIONAL BLUEPRINT

Diagnostic Biomarkers

Pulmonary Injury

• Surfactant proteins
• RAGE
• KL-6

Inflammation

• IL-6
• TNF-α
• CRP

Endothelial Injury

• Angiopoietin-2
• vWF

Bioenergetic Dysfunction

• Lactate
• Mitochondrial stress markers

Clinical Endpoints

Primary

• Survival without severe respiratory failure

Secondary

• Ventilator-free days
• Oxygenation improvement
• Prevention of fibrosis
• ICU-free days

FDA TRANSLATIONAL PATHWAY

Discovery

↓

Preclinical Lung Injury Models

↓

IND Submission

↓

Phase I Safety

↓

Phase II Pulmonary Recovery Studies

↓

Phase III ARDS Survival Trials

↓

NDA/BLA Submission

14. PROJECT RHENOVA — INTEGRATION PATHWAYS

RHENOVA-A

Pulmonary Interface Stabilization

RHENOVA-B

Endothelial Recovery

RHENOVA-C

Oxygenation Restoration

RHENOVA-D

Mitochondrial Rescue

RHENOVA-E

Fibrosis Prevention

RHENOVA-F

Respiratory Regeneration

15. NEXT STRATEGIC RESEARCH PATHWAYS

Priority 1

Maternal ARDS biomarker panels

Priority 2

Pulmonary endothelial therapeutics

Priority 3

Alveolar regeneration platforms

Priority 4

Precision oxygen-delivery systems

Priority 5

Mitochondrial rescue interventions

Priority 6

AI-enabled respiratory deterioration prediction

16. SCF DBI INTERPRETATION

Decentralized Biological Intelligence Failure

Cellular Layer

Pulmonary epithelial and endothelial cells lose the ability to maintain barrier integrity and efficient oxygen exchange.

Tissue Layer

Alveolar spaces become flooded with inflammatory fluid, impairing gas exchange.

Organ Layer

The lungs lose their capacity to effectively oxygenate blood.

System Layer

Respiratory, cardiovascular, immune, metabolic, and endothelial systems become progressively desynchronized.

Whole-Organism Layer

The maternal organism experiences collapse of its oxygen-exchange interface, leading to widespread cellular energy failure, organ dysfunction, and escalating mortality risk.

17. SCF LAYMAN’S SUMMARY

Acute Respiratory Distress Syndrome (ARDS) is a severe lung condition in which inflammation and fluid accumulation prevent the lungs from delivering enough oxygen to the body.

In the SCF framework, ARDS is viewed as a failure of the lung’s oxygen-exchange system. Damage to the lung’s tiny air sacs and blood vessels causes fluid leakage, making breathing difficult and reducing oxygen levels in the bloodstream.

Common symptoms include:

• Severe shortness of breath
• Rapid breathing
• Low oxygen levels
• Extreme fatigue
• Respiratory failure

ARDS is a medical emergency that usually requires intensive care and mechanical ventilation. Without rapid treatment, it can progress to multiple organ failure and death.

SCF-RDOS INDICATION SUMMARY

INDEX

SCF Master Registry Classification

• SCF-RDOS-PPD-PULM-001 — Acute Respiratory Distress Syndrome (ARDS)
• SCF-RDOS-PPD-INF-011 — Septic Shock
• SCF-RDOS-PPD-HEMO-001 — Hemorrhagic Shock
• SCF-RDOS-PPD-CRIT-001 — Multiple Organ Dysfunction Syndrome (MODS)
• SCF-RDOS-PPD-CRIT-002 — Maternal Critical Illness Syndrome (MCIS)

Domain Pathway

Postpartum Disorders → Pulmonary Disorders → Acute Respiratory Failure Syndromes → Acute Respiratory Distress Syndrome → Maternal Critical Illness Syndrome

Adaptive Modules Applied

Universal Core Module + Pulmonary Biology Expansion + Critical Care Expansion + Maternal Survival Biology Expansion + Endothelial Biology Expansion + Immunology Expansion + Mitochondrial Biology Expansion + Multi-Organ Systems Expansion

SCF Encyclopedia Series

Maternal Postpartum Disorders Encyclopedia (Pulmonary Critical Care, Respiratory Failure, Maternal Survival Biology & Systems Pathophysiology Volume) — Version 1.0.0